Press releases

Sanner Bubble Talk to one of our experts

Respiratory drug delivery has evolved far beyond the familiar “inhale and press” inhaler. Today, electronics are robust, mature, and cheap enough to optimize how inhalation devices generate aerosols, deliver medication accurately, monitor patient technique, and support adherence. From vibrating mesh nebulisers to breath-actuated smart inhalers, the integration of electronics is redefining what inhaled therapies can achieve.

This shift is not simply about adding technology for technology’s sake.…

May 12, 2026 – Sanner, a leading global healthcare packaging and medical device CDMO, has appointed Dirk Scholz as new Chief Financial Officer (CFO). He joined the company on May 2, 2026.

Dirk Scholz brings a wealth of expertise and a proven track record of more than 30 years in finance leadership and general management to his new position. “With his international experience with private equity backed businesses, as well as large industrial manufacturing companies, Dirk Scholz is the ideal fit…

April 23, 2026 – Device design specialist and CDMO Sanner and medical device company PulmoBioMed Ltd have teamed up to achieve CE marking for PBM-HaleTM, a deep-lung breath sampling platform. As the first technology to obtain saliva-free, deep distal lung samples non-invasively, the solution is now approved for clinical and research purposes across Europe and the U.S. Together, Sanner and PulmoBioMed co-developed the pioneering device from prototype to market entry and are now ready for series…

The global healthcare industry is undergoing significant transformation as geopolitical shifts, economic pressure, and regulatory changes reshape how pharmaceutical companies develop, manufacture, and distribute products. By partnering with CDMOs and desiccant packaging specialists like the Sanner Group, innovators can create the basis for long-term growth – across borders and from development to production.

Every year on St Patrick’s Day, the world celebrates Ireland - its heritage, its people, its resilience. But beyond the parades, music, and tropes, the Emerald Isle has another story worth telling: Ireland, both North and South, has become one of the world’s most dynamic, collaborative, and fast‑growing clusters for medical technology, drug‑delivery, digital health and advanced manufacturing. In short, its nuts.

 

For global innovators and scaling device companies, this island is more than a…

The global healthcare industry is entering a period of profound transformation. Geopolitical realignments, economic pressure, and regulatory change are reshaping how pharmaceutical and medical device companies design, develop, and manufacture products. For MedTech innovators and their partners, anticipating these shifts is no longer optional, it is a prerequisite for sustainable growth.

 

The Sanner Group has been participating in the EcoVadis sustainability assessment for around two years. After being awarded the Bronze rating at the beginning of the year, the company has now risen two levels to achieve the Gold status in October. This places Sanner among the top five percent of more than 150,000 companies assessed worldwide. The rating acknowledges outstanding results in environmental impact, labor practices and human rights, ethics, as well as sustainable procurement, and is…

At CPHI Frankfurt, Sanner Group will highlight its two strategic focus areas: Visitors to booth 0J92 in Hall 8 can discover Sanner’s expanded portfolio of global CDMO services for medical devices and complex pharmaceutical drug delivery systems. The company will also present its latest innovations in pharmaceutical packaging and advanced moisture management solutions.

Bensheim/Germany, August 8, 2025 – Sanner is setting the course for the future: As part of its strategic transformation into a CDMO (Contract Development and Manufacturing Organization) for medical devices and complex pharmaceutical drug delivery systems, the company announces a management change.

July 21, 2025 – Sanner, a global leader in high-quality healthcare packaging and drug delivery solutions, officially opened its first U.S.-based production facility in Greensboro, North Carolina, just weeks after commencing initial operations. This marks a strategic milestone in the company’s 134-year history: signaling a new era of innovation, customer proximity, and sustainable growth with localized production to better serve MedTech and pharmaceutical partners across North America.